PELVICOELIO: Use of Laparoscopy in the Treatment of Pelvic Ring Ruptures
Sponsor
University Hospital, Brest (Other)
Overall Status
Active, not recruiting
CT.gov ID
NCT05836727
Collaborator
(none)
14
1
3
4.6
Study Details
Study Description
Brief Summary
Case series to describe the use of laparoscopy for the treatment of pelvic ring disruption.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
14 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Use of Laparoscopy in the Treatment of Pelvic Ring Ruptures
Actual Study Start Date
:
Mar 1, 2023
Actual Primary Completion Date
:
Apr 1, 2023
Anticipated Study Completion Date
:
Jun 1, 2023
Outcome Measures
Primary Outcome Measures
- conversion rate to open surgery [intraoperative]
conversion rate to open surgery
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 100 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- patients who underwent laparoscopy for the treatment of pelvic ring disruption
Exclusion Criteria:
- patient < 18 years old
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Chu Brest | Brest | France | 29609 |
Sponsors and Collaborators
- University Hospital, Brest
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
University Hospital, Brest
ClinicalTrials.gov Identifier:
NCT05836727
Other Study ID Numbers:
- 29BRC23.0010 - PELVICOELIO
First Posted:
May 1, 2023
Last Update Posted:
May 1, 2023
Last Verified:
Feb 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Brest
Additional relevant MeSH terms: